Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
cancer
|
| gptkbp:age |
adults
older adults |
| gptkbp:associated_with |
metastasis
paraneoplastic syndromes |
| gptkbp:clinicalTrials |
Phase III trials
Phase I trials Phase II trials Phase IV trials |
| gptkbp:diseaseResistance |
gptkb:CT_scan
MRI ultrasound depends on stage 5-year survival rate |
| gptkbp:gender |
male
female |
| gptkbp:geneticDiversity |
gptkb:MET_gene_mutation
FLCN gene mutation VHL gene mutation |
| https://www.w3.org/2000/01/rdf-schema#label |
Kidney cancer
|
| gptkbp:impact |
surgery
kidneys radiation therapy immunotherapy targeted therapy |
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:provides |
gptkb:American_Cancer_Society
gptkb:National_Kidney_Foundation gptkb:Cancer_Research_UK gptkb:Kidney_Cancer_Association |
| gptkbp:research_focus |
patient outcomes
genetic factors early detection new treatments |
| gptkbp:riskManagement |
obesity
family history smoking high blood pressure |
| gptkbp:safetyFeatures |
regular exercise
healthy diet avoidance of tobacco control of blood pressure |
| gptkbp:symptoms |
fatigue
weight loss lower back pain blood in urine |
| gptkbp:type |
renal cell carcinoma
Wilms tumor transitional cell carcinoma |